This topic contains a solution. Click here to go to the answer

Author Question: School counselors should not facilitate school-based groups on drug and alcohol prevention due to ... (Read 107 times)

abc

  • Hero Member
  • *****
  • Posts: 543
School counselors should not facilitate school-based groups on drug and alcohol prevention due to the therapeutic nature of this topic.
 
  Indicate whether the statement is true or false

Question 2

The Butcher Treatment Planning Inventory (BTPI) is designed to:
 
  a. serve as a comprehensive instrument to generate case conceptualizations and treatment plans.
 b. assess client characteristics that may interfere with or facilitate counseling progress.
 c. assist counselors in establishing strong therapeutic alliances with clients.
 d. help clients identify community resources for support and treatment.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

honnalora

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

false

Answer to Question 2

b



abc

  • Hero Member
  • *****
  • Posts: 543
Both answers were spot on, thank you once again




 

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library